神经肿瘤学：端粒酶逆转录酶（TERT）启动子突变可能表明胶质母细胞瘤预后不良。 - Suppr

Suppr

超能文献

Neuro-oncology: TERT promoter mutations could indicate poor prognosis in glioblastoma.

作者信息

Malkki Hemi

出版信息

Nat Rev Neurol. 2014 Oct;10(10):546. doi: 10.1038/nrneurol.2014.168. Epub 2014 Sep 9.

DOI:10.1038/nrneurol.2014.168

PMID:25201236

Abstract

摘要

相似文献

Neuro-oncology: TERT promoter mutations could indicate poor prognosis in glioblastoma.神经肿瘤学：端粒酶逆转录酶（TERT）启动子突变可能表明胶质母细胞瘤预后不良。

Nat Rev Neurol. 2014 Oct;10(10):546. doi: 10.1038/nrneurol.2014.168. Epub 2014 Sep 9.

Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.TERT、EGFR和IDH状态的联合分析定义了不同预后的胶质母细胞瘤类别。

Neurology. 2015 May 12;84(19):2007. doi: 10.1212/WNL.0000000000001625.

Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.在经标准放化疗治疗的异柠檬酸脱氢酶1（IDH1）野生型原发性胶质母细胞瘤中，人端粒酶逆转录酶（TERT）启动子突变可使甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化带来生存优势。

Neuro Oncol. 2017 Mar 1;19(3):394-404. doi: 10.1093/neuonc/now189.

TERT Promoter Mutations Correlate with IDHs, MGMT and EGFR in Glioblastoma Multiforme.

Neurol India. 2021 Jan-Feb;69(1):135-136. doi: 10.4103/0028-3886.310071.

TERT promoter mutations in primary and secondary glioblastomas.原发性和继发性神经胶质瘤中的 TERT 启动子突变。

Acta Neuropathol. 2013 Dec;126(6):931-7. doi: 10.1007/s00401-013-1163-0. Epub 2013 Aug 17.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".cIMPACT-NOW更新3：“弥漫性星形细胞胶质瘤，IDH野生型，具有胶质母细胞瘤分子特征，WHO四级”的推荐诊断标准。

Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26.

Telomerase reverse transcriptase promoter mutation- and O-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?端粒酶逆转录酶启动子突变和 O6-甲基鸟嘌呤-DNA 甲基转移酶启动子甲基化介导的异柠檬酸脱氢酶野生型胶质母细胞瘤对替莫唑胺的敏感性：两者之间有联系吗？

Eur J Cancer. 2021 Apr;147:84-94. doi: 10.1016/j.ejca.2021.01.014. Epub 2021 Feb 22.

Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.TERT、EGFR和IDH状态的联合分析定义了不同预后的胶质母细胞瘤类别。

Neurology. 2014 Sep 23;83(13):1200-6. doi: 10.1212/WNL.0000000000000814. Epub 2014 Aug 22.

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.在 IDH 突变型和 IDH 野生型弥漫性胶质瘤中，使用端粒酶启动子突变来标记具有相互临床行为的特定分子亚群。

J Neurosurg. 2018 Apr;128(4):1102-1114. doi: 10.3171/2016.11.JNS16973. Epub 2017 Jun 16.

The Impact of Extensive Surgical Resection of Butterfly Glioblastomas on Outcomes in the Presence of TERT Mutation and EGFR Amplification: A Retrospective Cohort Study.广泛切除蝶骨胶质母细胞瘤对 TERT 突变和 EGFR 扩增患者结局的影响：一项回顾性队列研究。

Cancer Control. 2024 Jan-Dec;31:10732748241288121. doi: 10.1177/10732748241288121.

引用本文的文献

Assessment of MGMT and TERT Subtypes and Prognosis of Glioblastoma by Whole Tumor Apparent Diffusion Coefficient Histogram Analysis.通过全肿瘤表观扩散系数直方图分析评估胶质母细胞瘤的MGMT和TERT亚型及预后

Brain Behav. 2025 Jan;15(1):e70175. doi: 10.1002/brb3.70175.

Tumor treating fields in glioblastoma: long-term treatment and high compliance as favorable prognostic factors.胶质母细胞瘤中的肿瘤治疗电场：长期治疗和高依从性作为有利的预后因素。

Front Oncol. 2024 Mar 20;14:1345190. doi: 10.3389/fonc.2024.1345190. eCollection 2024.

The C250T Mutation of Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.与C228T突变相比，C250T突变对端粒和染色体产生的生物学效应较小，可能会使胶质母细胞瘤的预后更好。

Cancers (Basel). 2024 Feb 9;16(4):735. doi: 10.3390/cancers16040735.

Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase.多聚（U）结合剪接因子 60 通过转录上调端粒酶逆转录酶促进肾细胞癌生长。

Int J Biol Sci. 2020 Sep 25;16(15):3002-3017. doi: 10.7150/ijbs.45115. eCollection 2020.

Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients.中国人胶质母细胞瘤中异柠檬酸脱氢酶基因和端粒酶逆转录酶启动子突变的特征。

Brain Behav. 2020 Apr;10(4):e01583. doi: 10.1002/brb3.1583. Epub 2020 Mar 8.

Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.超越世界卫生组织浸润性神经胶质瘤分级：神经胶质瘤分类的分子遗传学进展。

Ann Transl Med. 2015 May;3(7):95. doi: 10.3978/j.issn.2305-5839.2015.03.57.

本文引用的文献

Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.TERT、EGFR和IDH状态的联合分析定义了不同预后的胶质母细胞瘤类别。

Neurology. 2014 Sep 23;83(13):1200-6. doi: 10.1212/WNL.0000000000000814. Epub 2014 Aug 22.

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.端粒酶逆转录酶（TERT）启动子突变：原发性胶质母细胞瘤中一种新的独立预后因素。

Neuro Oncol. 2015 Jan;17(1):45-52. doi: 10.1093/neuonc/nou158. Epub 2014 Aug 18.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验